Ret Proto-Oncogene Protein (RET) (His tag)

Produktnummer ABIN7579217

Recombinant Ret Proto-Oncogene-Protein exprimiert in Mammalian Cells.

Kurzübersicht für Ret Proto-Oncogene Protein (RET) (His tag) (ABIN7579217)

Target: Ret Proto-Oncogene (RET)

Protein-Typ: Recombinant

Spezies: Human

Quelle: Mammalian Cells

Applikation: Western Blotting (WB), SDS-PAGE (SDS), ELISA

Produktdetails

Aufreinigungstag / Konjugat: Dieses Ret Proto-Oncogene Protein ist gelabelt mit His tag.

Verwendungszweck: Recombinant Human RET/c-RET Protein, C-His

Sequenz: Leu29-Arg635

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute in sterile water for a stock solution.

Buffer: Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4 % Trehalose, 1 % Mannitol.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week . Store at -20 °C for twelve months from the date of receipt.

Antigendetails

Target: Ret Proto-Oncogene (RET)

Andere Bezeichnung: RET/c-RET

Hintergrund: RET51, Proto-oncogene c-Ret, Cadherin family member 12, RET, Proto-oncogene tyrosine-protein kinase receptor Ret, CDHF12, CDHR16, PTC

Molekulargewicht: 70.68 kDa

UniProt: P07949

Pathways: RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation